Composition and method for inhibition of nerve transmission
Abstract
The presently claimed and disclosed invention(s) provides a therapeutically effective composition and method of inhibiting nerve cell transmission. In a preferred embodiment of the presently claimed and disclosed invention(s), the treatment of neuropathic pain utilizing terpene compounds isolated from plant essential oils or manufactured synthetically is detailed. These compounds, such as geraniol and citronellol, as well as chemical analogs thereof, used in combination or individually, can be used alone or in a composition with a pharmaceutically acceptable carrier in a suitable dosage form.
Claims
exact text as granted — not AI-modified1 . A composition for the inhibition of nerve transmission comprising at least one terpene compound or a combination of terpene compounds and, optionally, one or more pharmaceutically acceptable diluent or excipient, wherein said terpene compound is selected from the group consisting of nerol, geraniol, neral, geranial, geranyl formate, geranyl butyrate, geranyl tiglate, citronellyl formate, neryl formate, isomenthone, citronellyl butyrate, citronellyl tiglate, menthone, rose oxide, and pharmaceutically acceptable isomers, salts, and esters thereof.
2 .- 25 . (canceled)Join the waitlist — get patent alerts
Track US2018207110A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.